Preliminary Data Shows Platform Generated Over $1.36 Million in Just 14 Days; Daily Revenue Velocity Accelerating Rapidly ...
NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, ...
The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...
LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug ...
NEW YORK, NY / ACCESS Newswire / December 15, 2025 / As the market has paid increasing attention to, and begun revaluing, SMX's potential across plastics, gold, rare earths, and hardware ...
GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...
Annual Meeting 2025 Highlights" report has been added to ResearchAndMarkets.com's offering. IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare ...
Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory ...
Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback